How HCV testing and care can be delivered through drug services: Evidence-base, case studies and 'real life' implementation experiences

Speakers

Hedrich

Dagmar

• EMCDDA

Schatz

Eberhard

• Correlation European Harm Reduction Network
• Netherlands

Presentation files

23 A2 1535 Dagmar Hedrich.pdf524.12 KBDownload

23 A2 1535 Eberhard Schatz .pdf483.78 KBDownload

Type

• Oral presentation

Tracks

• The future of hepatitis C among people who inject drugs: new frontiers for policy, practice and science

Keywords

• Infectious diseases
• Public health

Part of session

Enhancing the role of drug treatment services for HCV elimination among people who inject drugs